Semiautomated data analysis of flow cytometric estimation of fetomaternal hemorrhage in D- women

Transfusion

Volumn 42, Issue 8, 2002, Pages 1067-1078

  Greiss, M A ^a,b   Armstrong Fisher, S S ^a,b   Perera, W S ^a,b   Brown, P M ^a,b   Urbaniak, S J ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Regional Transfusion Service   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RHESUS D ANTIBODY;

ARTICLE; AUTOMATION; BLOOD; CALIBRATION; ERYTHROCYTE; FEMALE; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; GENETICS; HETEROZYGOTE; HUMAN; METABOLISM; PREGNANCY;

ANTIBODIES, MONOCLONAL; AUTOMATION; CALIBRATION; ERYTHROCYTES; FEMALE; FETOMATERNAL TRANSFUSION; FLOW CYTOMETRY; HETEROZYGOTE; HUMANS; PREGNANCY; RHO(D) IMMUNE GLOBULIN;

EID: 0036689235     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00159.x     Document Type: Article

References (29)

1. 1 Kelsey P, Reilly JT, Chapman JF, et al. BCSH Blood Transfusion and General Hematology Task Force Guidelines: The estimation of fetomaternal haemorrhage. Transfus Med 1999 ; 9: 87 ‐ 92.
2. 2 Crowther C, Middleton P. Anti D administration after childbirth for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev 2001 ; 2: CD000021.
3. 3 Pembrey ME, Weatherall DJ, Clegg JB. Maternal synthesis of haemoglobin F in pregnancy. Lancet 1973 ; 1: 1350 ‐ 4.
4. 4 Peters A, Rohloff D, Kohlmann T, et al. Fetal hemoglobin in starvation ketosis of young women. Blood 1998 ; 91: 691 ‐ 4.
5. 5 Mullis P, Schuler J, Zuppinger K. Increased prevalence of fetal haemoglobin in type 1 (insulin‐dependent) diabetes mellitus. Diabetologia 1989 ; 32: 227 ‐ 30.
6. 6 Diem P, Mullis P, Hirt A, et al. Fetal haemoglobin level in adult type 1 (insulin‐dependent) diabetic patients. Diabetologia 1993 ; 36: 129 ‐ 32.
7. 7 Rafaat A, Fraser N, Main R, Urbaniak SJ. A quality assurance scheme for the Kleihauer test: the Scottish experience 1988‐1996. Transfus Med 1997 ; 7: 221 ‐ 6.
8. 8 Nance SJ, Nelson JM, Arndt PA, et al. Quantitation of fetal‐maternal haemorrhage by flow cytometry: a simple and accurate method. Am J Clin Pathol 1989 ; 91: 288 ‐ 92.
9. 9 Duguid JK, Bromilow IM. Laboratory measurement of fetomaternal haemorrhage and its clinical relevance. Transfus Med Rev 1999 ; 13: 43 ‐ 8.
10. 10 Perera WS. Binding and molecular characterisation of monoclonal RhD antibodies (PhD thesis). Univ. of Aberdeen, Scotland; 1999.
11. 11 Scott ML, Voak D, Jones JW, et al. A model for RhD—the relationship of 30 serologically defined epitopes to predicted structure. Biotest Bull 1997 ; 5: 459 ‐ 66.
12. 12 Scott ML. Rh serology co‐ordinator's report. Transfus Clin Biol 1996 ; 3: 333 ‐ 7.
13. 13 Lloyd‐Evans P, Guest AR, Austin EB, Scott ML. Use of a phycoerythrin‐conjugated anti‐glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry. Transfus Med 1999 ; 9: 155 ‐ 60. DOI: 10.1046/j.1365-3148.1999.00187.x
14. 14 Arndt PA, Garratty G. Linear vs. logarithmic settings in flow cytometric analyses. Transfus Med 2000 ; 10: 321 ‐ 3. DOI: 10.1046/j.1365-3148.2000.00269.x
15. 15 Kumpel BM. Analysis of factors affecting quantification of fetomaternal hemorrhage by flow cytometry. Transfusion 2000 ; 40: 1376 ‐ 83. DOI: 10.1046/j.1537-2995.2000.40111376.x
16. 16 Johnson PRE, Tait RC, Austin EB, et al. Flow cytometry in diagnosis and management of large feto‐maternal haemorrhage. J Clin Pathol 1995 ; 48: 1005 ‐ 8.
17. 17 Bayliss KM, Kueck BD, Johnson ST, et al. Detecting fetomaternal hemorrhage: a comparison of five methods. Transfusion 1991 ; 31: 303 ‐ 7.
18. 18 Davis BH, Olsen S, Bigelow NC, Chen JC. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion 1998 ; 38: 749 ‐ 56.
19. 19 Pollack W. Mechanisms of Rh immune suppression by Rh immune globulin. In: Garratty G, editor. Hemolytic disease of the newborn. Arlington, VA: American Association of Blood Banks; 1984:53‐66.
20. 20 Pollack W, Ascari WQ, Kochesky RJ, et al. Studies on Rh prophylaxis. I. Relationship between doses of anti‐Rh and size of antigenic stimulus. Transfusion 1971 ; 11: 333 ‐ 9.
21. 21 Pollack W, Gorman JG. Rh immune suppression: an immunostat hypothesis. Symposium on Rh Antibody Mediated Immunosuppression, May 1975, Raritan, NJ. Ortho Res Inst Med Sci; 1976: p. 115‐24.
22. 22 Contreras M. Proceedings of the Joint Royal College of Physicians of Edinburgh and Royal College of Obstetricians and Gynaecologists. Consensus Conference on anti‐D prophylaxis, Edinburgh, Scotland [Urbaniak SJ, editor]. Br J Obstet Gynaecol 1998;105(Suppl 18):7‐10.
23. 23 Urbaniak SJ, Greiss MA. Rh haemolytic disease of the fetus and the newborn. Blood Rev 2000 ; 14: 44 ‐ 61. DOI: 10.1054/blre.1999.0123
24. 24 Issitt PD. Serology and genetics of the Rh blood group system. Ohio and London: Montgomery Scientific Publication; 1979:42.
25. 25 Kumpel BM. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti‐D. Transfusion 2001 ; 41: 1059 ‐ 63. DOI: 10.1046/j.1537-2995.2001.41081059.x
26. 26 Powell HJ, Austin EB, Makar Y, et al. Using flow cytometry to monitor inadvertent RhD positive transfusion (abstract). Transfus Clin Biol 2001 ; 8 (Suppl 1): 170s.
27. 27 Fong EA, Davies JI, Grey DE, et al. Detection of massive transplacental haemorrhage by flow cytometry. Clin Lab Haematol 2000 ; 22: 325 ‐ 7.
28. 28 Kumpel BM. Labelling RBC for flow cytometric quantitation of fetomaternal haemorrhage when the patient has received prophylactic anti‐D (abstract). Transfus Med 2000 ; 10 (Suppl 1): 31.
29. 29 Lloyd‐Evans P, Guest AR, Austin EB, Scott ML. Use of a phycoerythrin‐conjugated anti‐glycophorin A monoclonal antibody as a double label to improve the accuracy of FMH quantification by flow cytometry. Transfus Med 1999 ; 9: 155 ‐ 60. DOI: 10.1046/j.1365-3148.1999.00187.x